Search

Your search keyword '"Peter Sasieni"' showing total 378 results

Search Constraints

Start Over You searched for: Author "Peter Sasieni" Remove constraint Author: "Peter Sasieni"
378 results on '"Peter Sasieni"'

Search Results

1. Protocol for the YORKSURe prospective multistage study testing the feasibility for early detection of bladder cancer in populations with high disease-specific mortality risk

2. Total serum N-glycans associate with response to immune checkpoint inhibition therapy and survival in patients with advanced melanoma

3. A case–control study to evaluate the impact of the breast screening programme on breast cancer incidence in England

4. Exploring the utility and acceptability of Faecal immunochemical testing (FIT) as a novel intervention for the improvement of colorectal Cancer (CRC) surveillance in individuals with lynch syndrome (FIT for lynch study): a single-arm, prospective, multi-centre, non-randomised study

5. Impact of Barrett oesophagus diagnoses and endoscopies on oesophageal cancer survival in the UK: A cohort study

6. audit_cc: A Stata command for the analysis of matched case-control audits of cervical cancer screening

7. Rituximab versus tocilizumab and B-cell status in TNF-alpha inadequate-responder rheumatoid arthritis patients: the R4-RA RCT

8. Cervical cell lift: A novel triage method for the spatial mapping and grading of precancerous cervical lesions

9. Multizonal anogenital neoplasia in women: a cohort analysis

10. Patient-reported experiences and views on the Cytosponge test: a mixed-methods analysis from the BEST3 trial

11. Phase I clinical trial repurposing all-trans retinoic acid as a stromal targeting agent for pancreatic cancer

12. Economic evaluation of Cytosponge®-trefoil factor 3 for Barrett esophagus: A cost-utility analysis of randomised controlled trial data

13. A new pragmatic design for dose escalation in phase 1 clinical trials using an adaptive continual reassessment method

14. Annual mammographic screening to reduce breast cancer mortality in women from age 40 years: long-term follow-up of the UK Age RCT

15. Weekly COVID-19 testing with household quarantine and contact tracing is feasible and would probably end the epidemic

16. High-dose oral vitamin D supplementation and mortality in people aged 65–84 years: the VIDAL cluster feasibility RCT of open versus double-blind individual randomisation

17. Development and validation of a risk prediction model to diagnose Barrett's oesophagus (MARK-BE): a case-control machine learning approach

18. Barrett’s oESophagus trial 3 (BEST3): study protocol for a randomised controlled trial comparing the Cytosponge-TFF3 test with usual care to facilitate the diagnosis of oesophageal pre-cancer in primary care patients with chronic acid reflux

19. The acceptability of high resolution anoscopy examination in patients attending a tertiary referral centre

20. Systematic Review and Meta-Analysis of Individual Patient Data to Assess the Sensitivity of Cervical Cytology for Diagnosis of Cervical Cancer in Low- and Middle-Income Countries

21. Secondary Prevention of Cervical Cancer: ASCO Resource-Stratified Clinical Practice Guideline

22. E-cigarettes compared with nicotine replacement therapy within the UK Stop Smoking Services: the TEC RCT

23. Evaluation of Dried Blood Spots and Oral Fluids as Alternatives to Serum for Human Papillomavirus Antibody Surveillance

24. Assessing Peanut Consumption in a Population of Mothers and Their Children in the UK

25. Visual inspection after acetic acid (VIA) is highly heterogeneous in primary cervical screening in Amazonian Peru.

26. Cervical screening at age 50-64 years and the risk of cervical cancer at age 65 years and older: population-based case control study.

28. Interpreting the results of noninferiority trials—a review

30. Supplementary Methods, Tables 1-5, Figures 1-4 from Development and Validation of a Melanoma Risk Score Based on Pooled Data from 16 Case–Control Studies

31. Benefit of Biennial Fecal Occult Blood Screening on Colorectal Cancer in England: A Population-Based Case-Control Study

32. Self-sampling for cervical screening offered at the point of invitation: A cross-sectional study of preferences in England

33. Diagnosis, treatment and survival from bladder, upper urinary tract, and urethral cancers:real-world findings from NHS England between 2013 and 2019

34. Modelled mortality benefits of multi-cancer early detection screening in England

35. Overcoming challenges of translating deep-learning models for glioblastoma:the ZGBM consortium

36. Non-speculum sampling approaches for cervical screening in older women: randomised controlled trial

37. Author Correction: Electronic cigarettes versus nicotine patches for smoking cessation in pregnancy: a randomized controlled trial

38. Cell-Free DNA–Based Multi-Cancer Early Detection Test in an Asymptomatic Screening Population (NHS-Galleri): Design of a Pragmatic, Prospective Randomised Controlled Trial

39. Impact of changes to the interscreening interval and faecal immunochemical test threshold in the national bowel cancer screening programme in England: results from the FIT pilot study

40. Role of human papillomavirus (HPV) vaccination on HPV infection and recurrence of HPV related disease after local surgical treatment: systematic review and meta-analysis

41. A case–control study to evaluate the impact of the breast screening programme on breast cancer incidence in England

42. The influence of post-screening follow-up time and participant characteristics on estimates of overdiagnosis from lung cancer screening trials

44. Dynamic data-enabled stratified sampling for trial invitations with application in NHS-Galleri

45. Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis (R4RA): 16-week outcomes of a stratified, biopsy-driven, multicentre, open-label, phase 4 randomised controlled trial

46. Faecal immunochemical testing in bowel cancer screening: Estimating outcomes for different diagnostic policies

47. A case-control study to evaluate the impact of the breast screening programme on mortality in England

48. Comparison of immediate colposcopy, repeat conventional cytology and high‐risk human papillomavirus testing for the clinical management of atypical squamous cells of undetermined significance cytology in routine health services of Medellin, Colombia: The <scp>ASCUS‐COL</scp> trial

49. Cancer Screening, Surrogates of Survival, and the Soma

50. Impact of changes to cervical screening guidelines on age and interval at which women are tested: Population-based study

Catalog

Books, media, physical & digital resources